Abstract
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyReferences
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).JAMA. 2001; 285: 2486-2497
- Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.Arch Intern Med. 2001; 161: 1413-1419
- Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP).Circulation. 1996; 94: 2381-2388
- Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.JAMA. 1996; 276: 875-881
- Cardiovascular mortality and noncontraceptive use of estrogen in women.Circulation. 1987; 75: 1102-1109
- High density lipoprotein cholesterol and incidence of coronary heart disease. The Israeli Ischemic Heart Disease Study.Am J Epidemiol. 1979; 109: 296-308
- Cardiovascular disease in women.Am J Obstet Gynecol. 1988; 158: 1553-1560
- Exercise and survival in the very old.Am J Geriatr Cardiol. 1994; 3: 24-34
National Heart and Lung Institute Lipid Research Clinics Program Laboratory Methods Committee. Manual of Laboratory Operations: Lipid and Lipoprotein Analysis. 2 Ed. Washington, DC: US Government Printing Office, DHEW publication No 75–628, 1974
- Plasma lipoprotein levels as predictors of cardiovascular death in women.Arch Intern Med. 1993; 153: 2209-2216
- High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.Circulation. 1989; 79: 8-15
- Triglycerides and ischemic heart disease.Atherosclerosis Rev. 1991; 22: 75-79
- Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B.Am J Cardiol. 2001; 88: 265-269
- Management of primary hyperlipidemia.N Engl J Med. 1995; 332: 1491-1498
- Excess body weight. An under-recognized contributor to dyslipidemia in white American women.Arch Intern Med. 1994; 154: 401-410
- A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.Arch Intern Med. 1997; 157: 1186-1192
- Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.Am J Cardiol. 1996; 78: 409-414
- Variability of plasma HDL subclass concentrations in men and women over time.Arterioscler Thromb Vasc Biol. 1997; 17: 702-706
- Biological variability of cholesterol, triglycerides, low- and high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A-I and B.Clin Chem. 1994; 40: 574-578
- Trends in cholesterol knowledge and screening and hypercholesterolemia awareness and treatment, 1980–1992; The Minnesota Heart Survey.Arch Intern Med. 1997; 157: 2326-2332
- Time trends in the use of cholesterol-lowering agents in older adults.Arch Intern Med. 1998; 158: 1761-1768
- Effects of a low-fat diet on plasma lipoprotein levels.Arch Intern Med. 1986; 146: 1573-1577
- Life-style correlates of risk factor change in young adults.Am J Epidemiol. 1987; 125: 812-831
- Environmental determinants, liver function, and high density lipoprotein cholesterol levels.Am J Epidemiol. 1983; 117: 406-418
- Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.JAMA. 1995; 273: 199-208
- Regression models in clinical studies.J Natl Cancer Inst. 1988; 80: 1198-1202
Article info
Publication history
Footnotes
This study was supported by grant DK31801 from the National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.